Description

Cisplatina Accord (cisplatin) concentrate for infusions 1 mg/ml. 50 ml. №1 vial

Ingredients:

Each ml contains 1 mg of cisplatin as the active ingredient.

Dosage:

The dosage of Cisplatina Accord should be calculated based on the patient’s body surface area and renal function. It is administered intravenously under the supervision of a healthcare professional.

Indications:

Cisplatina Accord is indicated for the treatment of various types of cancers, including testicular, ovarian, bladder, and lung cancers. It works by interfering with the growth of cancer cells.

Contraindications:

Do not use Cisplatina Accord if you have a history of allergic reactions to cisplatin or similar drugs. It is contraindicated in patients with severe kidney problems.

Directions:

Follow the instructions provided by your healthcare provider for the proper administration of Cisplatina Accord. It is essential to stay hydrated during and after treatment.

Scientific Evidence:

Cisplatin, the active ingredient in Cisplatina Accord, has been extensively studied for its efficacy in treating various cancers. Research published in the “Journal of Clinical Oncology” has shown that cisplatin-based chemotherapy regimens are highly effective in the management of testicular cancer. Additionally, studies have demonstrated the role of cisplatin in improving survival rates in patients with ovarian cancer.

Additional Information:

It is important to monitor kidney function regularly during treatment with Cisplatina Accord, as cisplatin can cause nephrotoxicity. Patients may experience side effects such as nausea, vomiting, and hair loss, which should be reported to the healthcare provider. If you have any concerns or questions about Cisplatina Accord, consult your doctor for personalized advice.

Pharmacological Effects: Cisplatin exerts its antitumor effects by forming cross-links with DNA, leading to cell death. It is particularly effective against rapidly dividing cells, making it a cornerstone in the treatment of various cancers.

Clinical Trials: Clinical trials have demonstrated the efficacy of cisplatin in combination with other chemotherapy agents in improving overall survival and disease-free survival in cancer patients. Studies have also investigated the use of cisplatin in novel drug delivery systems to enhance its therapeutic effects and reduce toxicity.